Collaborative work to evaluate toxicity on male reproductive organs by repeated dose studies in rats. 9) Testicular toxicity in male rats given adriamycin for two or four weeks

Journal of Toxicological Sciences

Volumn 25, Issue SPEC. ISS, 2000, Pages 95-101

  Adachi, T ^a   Nishimura, T ^a   Imahie, H ^a   Yamamura, T ^a  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

Adriamycin; Period of administration; Testicular toxicity

Indexed keywords

DOXORUBICIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; MALE; MALE GENITAL SYSTEM; NONHUMAN; RAT; REPRODUCTIVE TOXICITY; SEMINIFEROUS TUBULE; SPERMATOGONIUM; TESTIS INJURY; WEIGHT REDUCTION;

ANIMALIA;

EID: 0033646855     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.25.specialissue_95     Document Type: Article

References (11)

1. Adriamycin (NSC-123127), a new antibiotic with antitumor activity
2. Adriamycin (NSC-123127) mode and mechanism of action
3. A multiple comparison procedure for compairng several treatment with a control
4. Statistics for toxicologists
5. Evaluation of recovery from cyclophosphamide testicular toxicity in rats
6. Effects of adriamycin, an anticancer drug showing testicular toxicity, on fertility in male rats
7. Testicular cytotoxicity of intravenous doxorubicin in rats
8. Quantitative histopathological study on adriamycin testicular toxicity in rats
9. Delayed effects of doxorubicin on spermatogenesis and endocrine function in rats
10. Mechanisms of testicular toxicity
11. Studies on the optimal treatment period and parameters for detection of male fertility disorder in rats - Introductory summary-